Clinical trial
A Randomized Controlled Trial Comparing the Efficacy of Transanal Irrigation With Navina Smart Versus Standard Bowel Care in Patients With Multiple Sclerosis
NCT04707976 is registered in ClinicalTrials.gov with Wellspect HealthCare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Comparing the Efficacy of Transanal Irrigation With Navina Smart Versus Standard Bowel Care in Patients With Multiple Sclerosis
- Lead sponsor
- Wellspect HealthCare
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- February 28, 2025
- Enrollment
- 92 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
fecal constipation, fecal incontinence, multiple sclerosis, neurogenic bowel (disorder)